Tumor and Vascular Disease
Conditions
Interventions
Gold Standard:Pathological clinical diagnosis results.
Index test:Compare 
the 
and 
of 
5.0T 
for 
detection 
Sponsors
Zhongnan Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 70 years, with the ability to act independently; 2. Agree to participate in this clinical trial and sign the informed consent; 3. One of the above-mentioned diseases is confirmed by clinical diagnosis.
Exclusion criteria
Exclusion criteria: 1. There are electronic implants, such as cardiac pacemakers, neurostimulators, insulin pumps, cochlear implants, etc.; 2. Those who have undergone aneurysm surgery and have intracranial aneurysm clips; 3. Those who have had heart surgery and have artificial heart valves; 4. There is a metal foreign body in the eye; 5. Metal implants and prostheses, or metal foreign bodies in other parts of the human body; 6. Women who are pregnant or have a pregnancy plan within three months, and are breastfeeding; 7. Critically ill patients who need to use a life support system; 8. Epilepsy patients and mentally ill patients; 9. Patients with claustrophobia; 10. History of previous allergic reaction to contrast agent, history of bronchial asthma, or other allergic diseases; 11. Acute or chronic severe renal injury (GFR < 30ml/min/1.73m2) or acute renal insufficiency caused by hepatorenal syndrome/perioperative period of liver transplantation; 12. Patients with known QT interval prolongation, patients with hypokalemia, receiving class IA (such as quinidine, procainamide) or class III (amiodarone, sotalol) antiarrhythmic drug patients; 13. Other situations in which the clinical trial investigators deem it inappropriate to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Countries
China
Contacts
Public ContactXu Haibo
Zhongnan Hospital of Wuhan University
Outcome results
None listed